Chronic News and Research

RSS

Aspen Dental celebrates first location in Texas

Aspen Dental celebrates its first location in Texas on Thursday, September 12 with the opening of a new practice at 6109 Highway 191 in Odessa. The new office in Texas means that Aspen Dental dentists and staff now proudly serve communities in 27 states across the country.

12 Sep 2013

Study: People who get occasional migraines are more likely to be obese

People who get occasional migraines are more likely to be obese than people who do not have migraines, according to a study published in the September 11, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.

12 Sep 2013

ClinicalRM signs contract with NIH to provide broad spectrum of services for STI CTG Program

Clinical Research Management, Inc. (ClinicalRM) – a full-service Contract Research Organization (CRO) providing services for basic and applied research, clinical trials, and regulatory support – announced today it was awarded a contract by the Department of Health and Human Services, National Institutes of Health, Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy and Infectious Diseases (NIAID).

12 Sep 2013

Big changes for addiction treatment predicted under Obamacare

An estimated 40 million people could enter treatment because the health law recognizes drug addiction and alcoholism as chronic diseases that must be covered by insurance plans, according to the California Health Report.

12 Sep 2013

North Carolina professor receives 2013 New Scholar in Aging Award from Ellison Medical Foundation

Li Qian, PhD, an assistant professor in the University of North Carolina School of Medicine, has received a 2013 New Scholar in Aging Award from the Ellison Medical Foundation.

12 Sep 2013

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine’s efficacy in treating asthma patients and is not currently approved for this indication.

11 Sep 2013

Financial incentives on hypertension care shows increased blood pressure control

In an examination of the effect of financial incentives on hypertension care at 12 outpatient clinics, physician-level (individual) financial incentives, but not practice-level or combined incentives, resulted in greater blood pressure control or appropriate response to uncontrolled blood pressure, according to a study in the September 11 issue of JAMA.

11 Sep 2013

Study shows huge cost implications in getting injured patients to appropriate trauma hospitals

During a three-year period in seven metropolitan areas in the western United States, the emergency medical services system sent more than 85,000 injured patients to major trauma hospitals who didn't need to go there - costing the health care system more than $130 million per year, according to an Oregon Health & Science University study published today in the journal Health Affairs.

11 Sep 2013

Szechuan pepper found to mimic sense of touch in brain

The science behind the tingling sensation caused by eating a popular Asian spice has been explained by researchers at UCL.

11 Sep 2013

Rutgers scientist finds important clue on origins of multiple sclerosis

The search for the cause of multiple sclerosis, a debilitating disease that affects up to a half million people in the United States, has confounded researchers and medical professionals for generations. But Steven Schutzer, a physician and scientist at Rutgers New Jersey Medical School, has now found an important clue why progress has been slow - it appears that most research on the origins of MS has focused on the wrong part of the brain.

11 Sep 2013

Personalized treatment may be effective in wild type cancers

As a woman in her mid-forties who didn't smoke, Elizabeth Lacasia never expected to be diagnosed with lung cancer. But in 2006, after she developed a persistent and serious cough, a chest X-ray and CT scan revealed several tumors in her lower left lung.

11 Sep 2013

Parent's guide book for caring children living with juvenile arthritis

Parents who have children with chronic autoimmune diseases like juvenile arthritis face a lifetime of obstacles and challenges and now there's a book to help them. In Living with Juvenile Arthritis: A Parent's Guide, author Kimberly Poston Miller shares with readers her hard-earned wisdom and experiences as the mother of two children living with juvenile arthritis and a number of related autoimmune conditions.

11 Sep 2013

Large numbers of kidney disease patients inappropriately prescribed statins to lower cholesterol

A new analysis concludes that large numbers of patients in advanced stages of kidney disease are inappropriately being prescribed statins to lower their cholesterol - drugs that offer them no benefit and may increase other health risks such as diabetes, dementia or muscle pain.

11 Sep 2013

US cancer care system in crisis

Delivery of cancer care in the U.S. is facing a crisis stemming from a combination of factors -- a growing demand for such care, a shrinking oncology work force, rising costs of cancer care, and the complexity of the disease and its treatment, says a new report from the Institute of Medicine.

11 Sep 2013

Safety labeling changes announced for extended-release and long-acting opioid analgesics

The U.S. Food and Drug Administration today announced class-wide safety labeling changes and new postmarket study requirements for all extended-release and long-acting opioid analgesics intended to treat pain.

11 Sep 2013

Roche Signs Up To $422.5M Collaboration With Inovio

...

10 Sep 2013

Weill Cornell Medical College gets $100M gift to launch Driving Discoveries, Changing Lives campaign

Weill Cornell Medical College announced today that it has received a $100 million gift from longtime benefactors Joan and Sanford I. Weill and the Weill Family Foundation to launch the Medical College's $300 million Driving Discoveries, Changing Lives campaign dedicated to using the most advanced scientific approaches to rapidly translate research breakthroughs into innovative treatments and therapies for patients.

10 Sep 2013

Boehringer Ingelheim completes patient enrolment for interferon-free hepatitis C treatment

Boehringer Ingelheim today announced the completion of patient enrolment for a Phase IIa clinical trial investigating a new interferon-free, all-oral, direct-acting antiviral combination treatment for patients with genotype-1a chronic hepatitis C virus infection.

10 Sep 2013

Relmada Therapeutics reports positive results from pivotal pharmacokinetic study of LevoCap ER

Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced a positive outcome of its pivotal pharmacokinetic study for LevoCap ER. Based on the positive outcome of this study, Relmada is now preparing the Phase III development program and is planning to submit a request with the FDA to discuss the final pathway to the New Drug Application for this product during the fourth quarter of this year.

10 Sep 2013

Patients with COPD show improvements in lung function with olodaterol

Data from the olodaterol Phase 3 clinical program, presented for the first time at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona, showed the addition of olodaterol 5 and 10 µg delivered once daily via the Respimat® inhaler provided improvements in lung function in patients with moderate to very severe chronic obstructive pulmonary disease (COPD).

10 Sep 2013

Chronic News and Research

Aspen Dental celebrates first location in Texas

Study: People who get occasional migraines are more likely to be obese

ClinicalRM signs contract with NIH to provide broad spectrum of services for STI CTG Program

Big changes for addiction treatment predicted under Obamacare

North Carolina professor receives 2013 New Scholar in Aging Award from Ellison Medical Foundation

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Financial incentives on hypertension care shows increased blood pressure control

Study shows huge cost implications in getting injured patients to appropriate trauma hospitals

Szechuan pepper found to mimic sense of touch in brain

Rutgers scientist finds important clue on origins of multiple sclerosis

Personalized treatment may be effective in wild type cancers

Parent's guide book for caring children living with juvenile arthritis

Large numbers of kidney disease patients inappropriately prescribed statins to lower cholesterol

US cancer care system in crisis

Safety labeling changes announced for extended-release and long-acting opioid analgesics

Roche Signs Up To $422.5M Collaboration With Inovio

Weill Cornell Medical College gets $100M gift to launch Driving Discoveries, Changing Lives campaign

Boehringer Ingelheim completes patient enrolment for interferon-free hepatitis C treatment

Relmada Therapeutics reports positive results from pivotal pharmacokinetic study of LevoCap ER

Patients with COPD show improvements in lung function with olodaterol

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News